Scarica l'app Stockscreener
12.10
4.80%
-0.61
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OCUL Giù?
Forum
Previsione
Precedente Chiudi:
$12.71
Aprire:
$12.75
Volume 24 ore:
2.41M
Relative Volume:
1.06
Capitalizzazione di mercato:
$2.11B
Reddito:
$61.10M
Utile/perdita netta:
$-138.36M
Rapporto P/E:
-8.963
EPS:
-1.35
Flusso di cassa netto:
$-90.59M
1 W Prestazione:
-5.54%
1M Prestazione:
-0.33%
6M Prestazione:
+57.14%
1 anno Prestazione:
+33.85%
Intervallo 1D:
$11.87
$12.75
Intervallo di 1 settimana:
$11.87
$13.07
Portata 52W:
$5.80
$13.85
Ocular Therapeutix Inc Stock (OCUL) Company Profile
Nome
Ocular Therapeutix Inc
Settore
Industria
Telefono
781-357-4000
Indirizzo
15 CROSBY DRIVE, BEDFORD, MA
Confronta OCUL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OCUL
Ocular Therapeutix Inc
|
12.10 | 2.21B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-15 | Iniziato | Chardan Capital Markets | Buy |
| 2025-04-08 | Iniziato | William Blair | Outperform |
| 2025-03-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-03-11 | Iniziato | Needham | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-20 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-31 | Ripresa | Piper Sandler | Overweight |
| 2024-02-09 | Iniziato | BofA Securities | Buy |
| 2023-04-21 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-10 | Ripresa | Berenberg | Buy |
| 2021-08-10 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-12-28 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-11-13 | Reiterato | Raymond James | Strong Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-05-21 | Downgrade | Cowen | Outperform → Market Perform |
| 2019-05-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-05-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2018-12-03 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-11-15 | Iniziato | Raymond James | Strong Buy |
| 2018-09-07 | Iniziato | Piper Jaffray | Overweight |
| 2017-10-24 | Iniziato | Guggenheim | Buy |
| 2017-07-26 | Iniziato | H.C. Wainwright | Buy |
| 2017-07-12 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2017-02-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-08-11 | Iniziato | JMP Securities | Mkt Outperform |
| 2016-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-10-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2015-08-13 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie
Ocular Therapeutix (NASDAQ:OCUL) Stock Price Down 5%Here's What Happened - MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) Earns Buy Rating from Analysts at Chardan Capital - MarketBeat
Goldman Sachs Group Inc. Has $4.27 Million Stock Position in Ocular Therapeutix, Inc. $OCUL - MarketBeat
Ocular Therapeutix, Inc. $OCUL Shares Sold by Woodline Partners LP - MarketBeat
Big Picture: Is Ocular Therapeutix Inc gaining market shareWeekly Investment Report & AI Driven Stock Movement Reports - خودرو بانک
Will Ocular Therapeutix Inc benefit from geopolitical trendsPortfolio Return Report & Trade Opportunity Analysis - khodrobank.com
Stop Loss: What makes Ocular Therapeutix Inc. stock attractive todayEarnings Growth Summary & Consistent Return Investment Signals - خودرو بانک
Can Ocular Therapeutix Inc stock outperform in a bear marketRate Hike & Daily Profit Maximizing Tips - خودرو بانک
Can Ocular Therapeutix Inc outperform in the next rally2025 Institutional Moves & Verified Entry Point Detection - خودرو بانک
Is Ocular Therapeutix Inc a defensive stockWeekly Investment Report & Low Drawdown Trading Strategies - khodrobank.com
Ocular Therapeutix's (OCUL) Investor Day to Spotlight AXPAXLI Program's Potential in Retinal Disease Treatment - Sahm
Breakouts Watch: Will Ocular Therapeutix Inc stock hit new highs in YEAR2025 Trading Recap & AI Based Trade Execution Alerts - khodrobank.com
Aug Retail: How much upside does Ocular Therapeutix Inc. have2025 Short Interest & Accurate Entry and Exit Point Alerts - khodrobank.com
Market Catalysts: Can Ocular Therapeutix Inc maintain its current growth rate2025 Institutional Moves & Low Drawdown Momentum Ideas - khodrobank.com
Patterns Watch: Is Ocular Therapeutix Inc a defensive stockMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - khodrobank.com
Levels Update: Is Ocular Therapeutix Inc forming bullish engulfing patternsJuly 2025 Reactions & Smart Allocation Stock Tips - khodrobank.com
Ocular Therapeutix (NASDAQ:OCUL) Coverage Initiated by Analysts at Chardan Capital - Defense World
Dow Update: Can Siyata Mobile Inc Equity Warrant navigate macro headwindsQuarterly Profit Report & Risk Controlled Stock Alerts - خودرو بانک
Geopolitics Watch: Whats Ocular Therapeutix Incs historical returnJuly 2025 Volume & Community Consensus Trade Signals - khodrobank.com
Aug Patterns: Can Ocular Therapeutix Inc outperform in the next rallyEarnings Trend Report & Precise Entry and Exit Recommendations - khodrobank.com
Hedge Fund Moves: Is Ocular Therapeutix Inc gaining market shareJuly 2025 Chart Watch & AI Powered Market Entry Ideas - khodrobank.com
Stop Loss: How is EBAY managing supply chain issuesJuly 2025 Movers & Consistent Return Strategy Ideas - خودرو بانک
CEO Moves: What are Ocular Therapeutix Inc.’s earnings expectationsGap Up & Low Risk High Reward Ideas - khodrobank.com
Chardan Capital Initiates Coverage of Ocular Therapeutix (OCUL) with Buy Recommendation - Nasdaq
Ocular Therapeutix (OCUL) Receives New Coverage with 'Buy' Rating and $21 PT | OCUL Stock News - GuruFocus
This Broadcom Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Chardan Capital Initiates Ocular Therapeutix at Buy With $21 Price Target - MarketScreener
Insider Trends: Can Ocular Therapeutix Inc. disrupt its industryMarket Risk Summary & Precise Swing Trade Alerts - khodrobank.com
Cubist Systematic Strategies LLC Acquires New Shares in Ocular Therapeutix, Inc. $OCUL - MarketBeat
Polar Asset Management Partners Inc. Lowers Stock Position in Ocular Therapeutix, Inc. $OCUL - MarketBeat
Ocular Therapeutix, Inc. $OCUL Shares Sold by Northern Trust Corp - MarketBeat
Analysts Set Ocular Therapeutix, Inc. (NASDAQ:OCUL) Price Target at $17.20 - MarketBeat
Panagora Asset Management Inc. Trims Stock Position in Ocular Therapeutix, Inc. $OCUL - MarketBeat
Adage Capital Partners GP L.L.C. Purchases 1,600,000 Shares of Ocular Therapeutix, Inc. $OCUL - MarketBeat
Ocular Hypertension Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Bausch + Lomb, Aerie Pharma, Santen Pharma, AbbVie (Allergan), Nicox, Kowa, Qlaris Bio, Noveome Bio - The Globe and Mail
Ocular Therapeutix gains amid takeover speculation - MSN
Ocular Therapeutix (NASDAQ:OCUL) Reaches New 12-Month HighHere's What Happened - MarketBeat
Ocular Therapeutix at Morgan Stanley Conference: Strategic Clinical Insights By Investing.com - Investing.com Canada
Ocular Therapeutix™ to Host Investor Day on September 30, 2025 | - GuruFocus
Ocular Therapeutix™ to Host Investor Day on September 30, 2025 - The Manila Times
Ocular Therapeutix: A High-Stakes Bet On Becoming The New Standard Of Care (NASDAQ:OCUL) - Seeking Alpha
Key deals this week: Ocular Therapeutix, CoreWeave, Air Lease, Cadence and more (AL:NYSE) - Seeking Alpha
Best data tools to analyze Ocular Therapeutix Inc. stockWeekly Market Summary & Target Return Focused Stock Picks - Newser
Is Ocular Therapeutix Inc. a candidate for recovery play2025 Key Lessons & AI Forecasted Entry and Exit Points - Newser
Can Ocular Therapeutix Inc. rally from current levelsEarnings Growth Summary & Growth-Oriented Investment Plans - Newser
Can Ocular Therapeutix Inc. disrupt its industryEarnings Summary Report & Real-Time Buy Zone Alerts - خودرو بانک
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Ocular Therapeutix Inc Azioni (OCUL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):